Cholesterol level increases greater with indinavir than saquinavir

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 1999年 / 755卷 / 1期
关键词：
Cholesterol; Treatment Group; Protease Inhibitor; Cholesterol Level; Ritonavir;
D O I：
10.2165/00128415-199907550-00004
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [21] SURFACTANT PROPHYLAXIS INCREASES COSTS AT GREATER-THAN-30 WEEKS
    BLOOM, BT
    DELMORE, P
    KATTWINKEL, J
    PEDIATRIC RESEARCH, 1994, 35 (04) : A217 - A217
  • [22] Clinical use of a simultaneous HPLC assay for indinavir, saquinavir, ritonavir, and nelfinavir in children and adults
    Walson, PD
    Cox, S
    Utkin, I
    Gerber, N
    Crim, L
    Brady, M
    Koranyi, K
    THERAPEUTIC DRUG MONITORING, 2003, 25 (05) : 588 - 592
  • [23] Corn fiber oil lowers plasma cholesterol levels and increases cholesterol excretion greater than corn oil and similar to diets containing soy sterols and soy stanols in hamsters
    Wilson, TA
    DeSimone, AP
    Romano, CA
    Nicolosi, RJ
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2000, 11 (09): : 443 - 449
  • [24] Acute hepatitis in a patient treated with saquinavir and ritonavir: Absence of cross-toxicity with indinavir
    B. Vandercam
    M. Moneau
    C. Horsmans
    J. L. Gala
    Infection, 1998, 26 : 313 - 313
  • [25] Saquinavir/ritonavir have better short term antiviral efficacy than either ritonavir or indinavir in HIV-infected antiretroviral naive patients.
    Gerstoft, J
    Kirk, O
    Katzenstein, T
    Mathiesen, L
    Nielsen, H
    Lundgren, JD
    Pedersen, C
    AIDS, 1998, 12 : S9 - S9
  • [26] ANALYTICAL FUNCTIONS IN ELEMENTS VALUED AT A LEVEL GREATER THAN ONE
    PERRIN, Y
    COMPOSITIO MATHEMATICA, 1983, 49 (01) : 51 - 74
  • [27] Ritonavir + saquinavir better tolerated than ritonavir?
    Reactions Weekly, 1999, 775 (1) : 6 - 6
  • [28] The unbound percentage of saquinavir and indinavir remains constant throughout the dosing interval in HIV positive subjects
    Boffito, M
    Hoggard, PG
    Reynolds, HE
    Bonora, S
    Meaden, ER
    Sinicco, A
    Di Perri, G
    Back, DJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (03) : 262 - 268
  • [29] A phase II trial of dual protease inhibitor therapy: Amprenavir in combination with indinavir, nelfinavir, or saquinavir
    Eron, JJ
    Haubrich, R
    Lang, W
    Pagano, G
    Millard, J
    Wolfram, J
    Snowden, W
    Pedneault, L
    Tisdale, M
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (05) : 458 - 461
  • [30] Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir
    Eagling, VA
    Back, DJ
    Barry, MG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (02) : 190 - 194
12345